Pharmaceutical

Scorpion Therapeutics secures $150m for oncology pipeline

Scorpion Therapeutics has secured $150m in a Series C financing round to progress the development of its clinical-stage oncology pipeline.

Jul 18, 2024 - 04:00
Scorpion Therapeutics secures $150m for oncology pipeline
Scorpion Therapeutics has secured $150m in a Series C financing round to progress the development of its clinical-stage oncology pipeline.
Read the original article

Tags:

Previous Article

The US Biosecure Act threatens to destabilise the pharmaceutical industry 

Next Article

China NMPA approves Zai Lab-argenx’s efgartigimod alfa for gMG

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

Coherus acquires immuno-oncology company Surface

Coherus acquires immuno-oncology company Surface

Sep 11, 2023

STAT+: With an age cutoff for a new gene therapy, families and doctors scramble to treat kids before their 6th birthday

STAT+: With an age cutoff for a new gene therapy, famil...

Aug 17, 2023

The future of health care in the House

The future of health care in the House

Oct 6, 2023